Why Science? | ICH E2A Clinical Safety Definitions and Expedited Reporting

E2A defines an adverse event as an untoward medical occurrence in someone given a pharmaceutical product, whether or not it is considered related. It can be a sign, symptom, disease or abnormal laboratory finding temporally associated with treatment.

The strength of an adverse event does not require causality begins with naming the observation accurately. E2A defines an adverse event as an untoward medical occurrence in someone given a pharmaceutical product, whether or not it is considered related. It can be a sign, symptom, disease or abnormal laboratory finding temporally associated with treatment. Keep this boundary visible: Timing after treatment is not proof that the medicine caused the event.

A strong science note separates observation from interpretation. Write an observation-only description before adding any causal interpretation. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Next chapter

FDA identifies E2A as final guidance dated March 1995 under docket FDA-1993-D-0128 and issued by CDER. It harmonises collection, evaluation and rapid communication of important clinical-development safety information.

For the march 1995 e2a guidance is final, classification is a route to action rather than paperwork. FDA identifies E2A as final guidance dated March 1995 under docket FDA-1993-D-0128 and issued by CDER. It harmonises collection, evaluation and rapid communication of important clinical-development safety information. Preserve this guardrail: Current national or regional reporting rules may add requirements beyond the harmonised principles.

A strong science note separates observation from interpretation. Create a source receipt with title, status, date, docket, office, purpose and applicable jurisdiction. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

In preapproval development, an adverse drug reaction is a noxious and unintended response for which a causal relationship is at least a reasonable possibility and cannot be ruled out. This separates observed events from suspected medicine-related responses.

A fast safety report about an adverse drug reaction includes suspected causality can be preliminary and still be scientifically honest. In preapproval development, an adverse drug reaction is a noxious and unintended response for which a causal relationship is at least a reasonable possibility and cannot be ruled out. This separates observed events from suspected medicine-related responses. Remember: A suspicion threshold supports reporting; it does not establish proven causation.

A strong science note separates observation from interpretation. List evidence for and against a causal relationship without collapsing uncertainty into yes or no. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

An unexpected adverse reaction has a nature or severity not consistent with applicable product information, such as the Investigator’s Brochure for an unapproved medicine. Known reactions that are substantially more specific or severe can also add unexpected information.

The strength of unexpectedness is judged against reference information begins with naming the observation accurately. An unexpected adverse reaction has a nature or severity not consistent with applicable product information, such as the Investigator’s Brochure for an unapproved medicine. Known reactions that are substantially more specific or severe can also add unexpected information. Keep this boundary visible: Unexpected does not mean unforeseeable in ordinary language; it is a comparison with the designated reference.

A strong science note separates observation from interpretation. Quote the relevant reference concept, then show exactly how the case differs. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

A serious event or reaction results in death, is life-threatening at the time, requires or prolongs inpatient hospitalisation, causes persistent or significant disability or incapacity, or is a congenital anomaly or birth defect. Medical judgment also identifies other important events that may require intervention to prevent such outcomes.

For seriousness follows outcomes and medical significance, classification is a route to action rather than paperwork. A serious event or reaction results in death, is life-threatening at the time, requires or prolongs inpatient hospitalisation, causes persistent or significant disability or incapacity, or is a congenital anomaly or birth defect. Medical judgment also identifies other important events that may require intervention to prevent such outcomes. Preserve this guardrail: A serious classification depends on the actual case and relevant judgment, not merely an alarming diagnosis label.

A strong science note separates observation from interpretation. Map the case to each seriousness criterion and document the evidence supporting the selected one. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

An event may be mild, moderate or severe in intensity without meeting a serious outcome criterion. A severe headache can be non-serious; a modest symptom can prompt hospitalisation and be serious. Keeping the concepts separate prevents over- and under-reporting.

A fast safety report about severity describes intensity, not reporting category can be preliminary and still be scientifically honest. An event may be mild, moderate or severe in intensity without meeting a serious outcome criterion. A severe headache can be non-serious; a modest symptom can prompt hospitalisation and be serious. Keeping the concepts separate prevents over- and under-reporting. Remember: Intensity scales do not replace the seriousness assessment.

A strong science note separates observation from interpretation. Classify three example events independently for severity and seriousness. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

E2A clarifies that life-threatening means the patient was at risk of death at the time of the event. It does not mean an event that could hypothetically have caused death if it had been more severe.

The strength of life-threatening refers to actual immediate risk begins with naming the observation accurately. E2A clarifies that life-threatening means the patient was at risk of death at the time of the event. It does not mean an event that could hypothetically have caused death if it had been more severe. Keep this boundary visible: Speculation about a worse counterfactual should not substitute for the documented clinical state.

A strong science note separates observation from interpretation. Record vital signs, interventions and clinician judgment supporting or rejecting immediate risk. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Some events may not initially cause death, hospitalisation or disability but can jeopardise the patient or require intervention to prevent a serious outcome. Examples depend on medical judgment and context, including certain laboratory abnormalities, dependency or urgent treatment.

For medical importance can make an event serious, classification is a route to action rather than paperwork. Some events may not initially cause death, hospitalisation or disability but can jeopardise the patient or require intervention to prevent a serious outcome. Examples depend on medical judgment and context, including certain laboratory abnormalities, dependency or urgent treatment. Preserve this guardrail: Medical importance should be reasoned and documented rather than used as an automatic catch-all.

A strong science note separates observation from interpretation. Write the plausible prevented outcome and the intervention that made the event medically important. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Single cases that are both serious and unexpected and have a reasonable suspected causal relationship generally qualify for expedited reporting during development. These dimensions should be assessed separately before the reporting decision.

A fast safety report about expedited reporting focuses on serious unexpected adrs can be preliminary and still be scientifically honest. Single cases that are both serious and unexpected and have a reasonable suspected causal relationship generally qualify for expedited reporting during development. These dimensions should be assessed separately before the reporting decision. Remember: An expedited case report is an alert for prompt evaluation, not a final proof of the medicine’s risk.

A strong science note separates observation from interpretation. Use a three-column serious-unexpected-related decision card for each case. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Temporal relationship, dechallenge, rechallenge, biological plausibility, dose response, concomitant treatment and competing illness can inform whether a reasonable causal relationship exists. Investigators and sponsors may differ, and both assessments can be relevant.

The strength of causality should reflect evidence and alternatives begins with naming the observation accurately. Temporal relationship, dechallenge, rechallenge, biological plausibility, dose response, concomitant treatment and competing illness can inform whether a reasonable causal relationship exists. Investigators and sponsors may differ, and both assessments can be relevant. Keep this boundary visible: A missing alternative explanation does not by itself prove causation.

A strong science note separates observation from interpretation. Build a causality timeline and list the strongest drug and non-drug explanations. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Qualifying fatal or life-threatening serious unexpected adverse reactions should be reported as soon as possible and no later than seven calendar days after the sponsor first knows the case qualifies. A report as complete as possible follows within eight additional calendar days.

For fatal or life-threatening cases use a seven-day clock, classification is a route to action rather than paperwork. Qualifying fatal or life-threatening serious unexpected adverse reactions should be reported as soon as possible and no later than seven calendar days after the sponsor first knows the case qualifies. A report as complete as possible follows within eight additional calendar days. Preserve this guardrail: The clock does not wait for perfect information or final causality certainty.

A strong science note separates observation from interpretation. Mark awareness, qualification, initial report and follow-up deadlines on a calendar. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Serious unexpected adverse reactions that are not fatal or life-threatening should be filed as soon as possible and no later than fifteen calendar days after first knowledge that the minimum reporting criteria are met.

A fast safety report about other qualifying serious unexpected adrs use fifteen days can be preliminary and still be scientifically honest. Serious unexpected adverse reactions that are not fatal or life-threatening should be filed as soon as possible and no later than fifteen calendar days after first knowledge that the minimum reporting criteria are met. Remember: Fifteen days is an outer limit, not a reason to delay a ready report.

A strong science note separates observation from interpretation. Create an intake workflow that identifies day zero and escalates approaching deadlines. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

E2A lists an identifiable patient, identifiable reporting source, suspect medicinal product and identifiable serious unexpected event or outcome with a reasonable suspected causal relationship for clinical-investigation cases as minimum information. Missing details should be actively pursued.

The strength of minimum information supports an initial report begins with naming the observation accurately. E2A lists an identifiable patient, identifiable reporting source, suspect medicinal product and identifiable serious unexpected event or outcome with a reasonable suspected causal relationship for clinical-investigation cases as minimum information. Missing details should be actively pursued. Keep this boundary visible: Anonymous rumours or cases without an identifiable event cannot be evaluated as valid expedited reports.

A strong science note separates observation from interpretation. Check each minimum field and open a dated follow-up request for every missing detail. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

Initial reports may lack hospital records, laboratory values, diagnoses, outcome or exposure detail. Sponsors should seek relevant information and submit significant follow-up promptly. Version control should connect updates so reviewers do not count one person as several cases.

For follow-up turns an alert into a useful case, classification is a route to action rather than paperwork. Initial reports may lack hospital records, laboratory values, diagnoses, outcome or exposure detail. Sponsors should seek relevant information and submit significant follow-up promptly. Version control should connect updates so reviewers do not count one person as several cases. Preserve this guardrail: A rapid initial report does not remove the duty to investigate and correct the record.

A strong science note separates observation from interpretation. Build a follow-up checklist and record source, request date, receipt date and change to interpretation. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

When treatment assignment affects whether a case qualifies or how it is evaluated, unblinding may be needed for safety reporting. The process should protect trial integrity as far as possible while ensuring regulators and investigators receive necessary information.

A fast safety report about blinding needs a safety-aware procedure can be preliminary and still be scientifically honest. When treatment assignment affects whether a case qualifies or how it is evaluated, unblinding may be needed for safety reporting. The process should protect trial integrity as far as possible while ensuring regulators and investigators receive necessary information. Remember: Preserving blinding never overrides urgent participant protection or required reporting.

A strong science note separates observation from interpretation. Define who may unblind, for what trigger, how access is limited and how the action is documented. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

E2A recognises that findings beyond a single qualifying case can demand prompt attention, such as a clinically important increase in a known serious reaction, a major hazard from animal data or a lack of efficacy in a life-threatening disease.

The strength of other observations may require rapid communication begins with naming the observation accurately. E2A recognises that findings beyond a single qualifying case can demand prompt attention, such as a clinically important increase in a known serious reaction, a major hazard from animal data or a lack of efficacy in a life-threatening disease. Keep this boundary visible: A formal case category should not become a barrier to communicating an urgent emerging risk.

A strong science note separates observation from interpretation. Create escalation criteria for patterns and non-case findings that could change trial conduct. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter · Next chapter

The receipt records patient and reporter identifiers, suspect product, event narrative, dates, dose, seriousness criterion, severity, expectedness reference, causality evidence, concomitant factors, outcome, reporting clock, recipients, unblinding, follow-up and version history. It reveals why and when the case moved.

For a complete e2a receipt makes the decision traceable, classification is a route to action rather than paperwork. The receipt records patient and reporter identifiers, suspect product, event narrative, dates, dose, seriousness criterion, severity, expectedness reference, causality evidence, concomitant factors, outcome, reporting clock, recipients, unblinding, follow-up and version history. It reveals why and when the case moved. Preserve this guardrail: A complete report improves evaluation but cannot by itself establish population-level incidence or causation.

A strong science note separates observation from interpretation. Give the receipt to an independent reviewer and ask them to reproduce the classification and deadline. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.

Contents · Previous chapter